AMRI CFO to Present at the Rodman & Renshaw Annual Global Investment Conference

ALBANY, N.Y.--(BUSINESS WIRE)--AMRI (NASDAQ: AMRI) announced today that AMRI Senior Vice President, Administration and Chief Financial Officer Mark T. Frost will present at the Rodman & Renshaw Annual Global Investment Conference being held in New York City on Monday, September 13, 2010 at 12:05 p.m. EDT.

An audio webcast of the corporate presentation will be available to investors and interested parties by accessing the company’s website at www.amriglobal.com. In addition, a replay of the webcast will be available one hour after the live webcast through December 14, 2010.

Founded in 1991, Albany Molecular Research, Inc. (AMRI) provides scientific services, products and technologies focused on improving the quality of life. AMRI works on drug discovery and development projects and conducts manufacturing of active ingredients and pharmaceutical intermediates for many of the world's leading healthcare companies. As an additional value added service to its customers, the company is also investing in R&D in order to expand its contract services and to identify novel early stage drug candidates with the goal to outlicense to a strategic partner. With locations in the U.S., Europe, and Asia, AMRI provides customers with a wide range of services, technologies and cost models.